A 52-week open-label study to investigate tolerability of rivastigmine switching from oral capsule to transdermal patch in mild to moderate Alzheimer’s disease patients in Taiwan

2017 ◽  
Vol 381 ◽  
pp. 1030-1031
Author(s):  
J.L. Fuh ◽  
T.F. Chen ◽  
T.H. Lan ◽  
Y.W. Yang ◽  
C.F. Tsai ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Transdermal Patch ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Oral Capsule

Gait Changes with Anti-Dementia Drugs: A Prospective, Open-Label Study Combining Single and Dual Task Assessments in Patients with Alzheimer’s Disease

Drugs & Aging ◽  
2014 ◽  
Vol 31 (5) ◽  
pp. 363-372 ◽  
Author(s):  
Olivier Beauchet ◽  
Cyrille P. Launay ◽  
Gilles Allali ◽  
François R. Herrmann ◽  
Cedric Annweiler
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Dual Task ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document